These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

711 related articles for article (PubMed ID: 16409190)

  • 1. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual vaccines based on wild-type recombinant allergens.
    Van Overtvelt L; Razafindratsita A; St-Lu N; Didierlaurent A; Batard T; Lombardi V; Martin E; Moingeon P
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):247-9. PubMed ID: 17124785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological mechanisms of sublingual immunotherapy.
    Akdis CA; Barlan IB; Bahceciler N; Akdis M
    Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in allergen immunotherapy.
    Nouri-Aria KT
    Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
    Ciprandi G; Tosca MA; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
    Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
    Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological mechanisms of sublingual allergen-specific immunotherapy.
    Novak N; Bieber T; Allam JP
    Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of allergen specific immunotherapy--T-cell tolerance and more.
    Jutel M; Akdis M; Blaser K; Akdis CA
    Allergy; 2006 Jul; 61(7):796-807. PubMed ID: 16792576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sublingual immunotherapy: from biological extracts to recombinant allergens.
    Moingeon P
    Allergy; 2006; 61 Suppl 81():15-9. PubMed ID: 16792601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J; Jacobsen L; Valovirta E
    Allergy; 2006 Oct; 61(10):1184-90. PubMed ID: 16942566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting dendritic cells in allergen immunotherapy.
    Novak N
    Immunol Allergy Clin North Am; 2006 May; 26(2):307-19, viii. PubMed ID: 16701146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of allergen-specific immunotherapy: T-regulatory cells and more.
    Verhagen J; Blaser K; Akdis CA; Akdis M
    Immunol Allergy Clin North Am; 2006 May; 26(2):207-31, vi. PubMed ID: 16701141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.
    Razafindratsita A; Saint-Lu N; Mascarell L; Berjont N; Bardon T; Betbeder D; Van Overtvelt L; Moingeon P
    J Allergy Clin Immunol; 2007 Aug; 120(2):278-85. PubMed ID: 17531296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4.
    Piconi S; Trabattoni D; Rainone V; Borgonovo L; Passerini S; Rizzardini G; Frati F; Iemoli E; Clerici M
    J Immunol; 2010 Dec; 185(12):7723-30. PubMed ID: 21076061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
    Allam JP; Stojanovski G; Friedrichs N; Peng W; Bieber T; Wenzel J; Novak N
    Allergy; 2008 Jun; 63(6):720-7. PubMed ID: 18445186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.